IBDEI0QS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13178,1,4,0)
 ;;=4^425.4
 ;;^UTILITY(U,$J,358.3,13178,1,5,0)
 ;;=5^Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,13178,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,13179,0)
 ;;=414.00^^81^826^8
 ;;^UTILITY(U,$J,358.3,13179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13179,1,4,0)
 ;;=4^414.00
 ;;^UTILITY(U,$J,358.3,13179,1,5,0)
 ;;=5^CAD,Unsp Vsl
 ;;^UTILITY(U,$J,358.3,13179,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,13180,0)
 ;;=272.4^^81^826^12
 ;;^UTILITY(U,$J,358.3,13180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13180,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,13180,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,13180,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,13181,0)
 ;;=458.9^^81^826^14
 ;;^UTILITY(U,$J,358.3,13181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13181,1,4,0)
 ;;=4^458.9
 ;;^UTILITY(U,$J,358.3,13181,1,5,0)
 ;;=5^Hypotension
 ;;^UTILITY(U,$J,358.3,13181,2)
 ;;=^60729
 ;;^UTILITY(U,$J,358.3,13182,0)
 ;;=414.01^^81^826^4
 ;;^UTILITY(U,$J,358.3,13182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13182,1,4,0)
 ;;=4^414.01
 ;;^UTILITY(U,$J,358.3,13182,1,5,0)
 ;;=5^Arterioscler Hrt Disease
 ;;^UTILITY(U,$J,358.3,13182,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,13183,0)
 ;;=706.1^^81^827^2
 ;;^UTILITY(U,$J,358.3,13183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13183,1,4,0)
 ;;=4^706.1
 ;;^UTILITY(U,$J,358.3,13183,1,5,0)
 ;;=5^Acne
 ;;^UTILITY(U,$J,358.3,13183,2)
 ;;=^87239
 ;;^UTILITY(U,$J,358.3,13184,0)
 ;;=702.0^^81^827^3
 ;;^UTILITY(U,$J,358.3,13184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13184,1,4,0)
 ;;=4^702.0
 ;;^UTILITY(U,$J,358.3,13184,1,5,0)
 ;;=5^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,13184,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,13185,0)
 ;;=704.00^^81^827^5
 ;;^UTILITY(U,$J,358.3,13185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13185,1,4,0)
 ;;=4^704.00
 ;;^UTILITY(U,$J,358.3,13185,1,5,0)
 ;;=5^Alopecia Nos
 ;;^UTILITY(U,$J,358.3,13185,2)
 ;;=^5078
 ;;^UTILITY(U,$J,358.3,13186,0)
 ;;=709.9^^81^827^25
 ;;^UTILITY(U,$J,358.3,13186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13186,1,4,0)
 ;;=4^709.9
 ;;^UTILITY(U,$J,358.3,13186,1,5,0)
 ;;=5^Skin Lesion
 ;;^UTILITY(U,$J,358.3,13186,2)
 ;;=^111083
 ;;^UTILITY(U,$J,358.3,13187,0)
 ;;=682.9^^81^827^1
 ;;^UTILITY(U,$J,358.3,13187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13187,1,4,0)
 ;;=4^682.9
 ;;^UTILITY(U,$J,358.3,13187,1,5,0)
 ;;=5^Abcess/Cellulitis NOS
 ;;^UTILITY(U,$J,358.3,13187,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,13188,0)
 ;;=708.0^^81^827^4
 ;;^UTILITY(U,$J,358.3,13188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13188,1,4,0)
 ;;=4^708.0
 ;;^UTILITY(U,$J,358.3,13188,1,5,0)
 ;;=5^Allergic Urticaria
 ;;^UTILITY(U,$J,358.3,13188,2)
 ;;=^259112
 ;;^UTILITY(U,$J,358.3,13189,0)
 ;;=707.00^^81^827^12
 ;;^UTILITY(U,$J,358.3,13189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13189,1,4,0)
 ;;=4^707.00
 ;;^UTILITY(U,$J,358.3,13189,1,5,0)
 ;;=5^Decubitus Ulcer,Site NOS
 ;;^UTILITY(U,$J,358.3,13189,2)
 ;;=^336880
 ;;^UTILITY(U,$J,358.3,13190,0)
 ;;=707.06^^81^827^6
 ;;^UTILITY(U,$J,358.3,13190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13190,1,4,0)
 ;;=4^707.06
 ;;^UTILITY(U,$J,358.3,13190,1,5,0)
 ;;=5^Decubitus Ulcer,Ankle
 ;;^UTILITY(U,$J,358.3,13190,2)
 ;;=^336839
 ;;^UTILITY(U,$J,358.3,13191,0)
 ;;=707.05^^81^827^7
 ;;^UTILITY(U,$J,358.3,13191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13191,1,4,0)
 ;;=4^707.05
 ;;^UTILITY(U,$J,358.3,13191,1,5,0)
 ;;=5^Decubitus Ulcer,Buttock
 ;;^UTILITY(U,$J,358.3,13191,2)
 ;;=^336838
 ;;^UTILITY(U,$J,358.3,13192,0)
 ;;=707.07^^81^827^8
